Legionnaires disease is atypical pneumonia caused by legionella bacteria.
This report contains market size and forecasts of Legionnaire Disease Testing in Global, including the following market information:
Global Legionnaire Disease Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Legionnaire Disease Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Urinary Antigen Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Legionnaire Disease Testing include Danaher, Bio-Rad, Abbott, Roche, Thermo Fischer Scientific, BD, Aquacert, BioMérieux and Idexx and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Legionnaire Disease Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Legionnaire Disease Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Legionnaire Disease Testing Market Segment Percentages, by Type, 2021 (%)
Urinary Antigen Testing
Direct Fluorescent Antibody (DFA) Stain
Combination Testing (Culture and Urinary Antigen Testing)
Others
Global Legionnaire Disease Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Legionnaire Disease Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Diagnostic Laboratories
Research Centers
Others
Global Legionnaire Disease Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Legionnaire Disease Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Legionnaire Disease Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Legionnaire Disease Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Danaher
Bio-Rad
Abbott
Roche
Thermo Fischer Scientific
BD
Aquacert
BioMérieux
Idexx
Albagaia